Related Experiment Video
Updated: May 29, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Molecular-weight-dependent, anionic-substrate-preferential transport of β-lactam antibiotics via multidrug
Shin-Ichi Akanuma1, Yasuo Uchida, Sumio Ohtsuki
1Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Abstract:
β-Lactam antibiotics have cerebral and peripheral adverse effects. Multidrug resistance-associated protein 4 (MRP4) has been reported to transport several β-lactam antibiotics, and its expression at the blood-brain barrier also serves to limit their distribution to the brain. Therefore, the purpose of this study was to clarify the structure-activity relationship of MRP4-mediated transport of β-lactam antibiotics using MRP4-expressing Sf9 membrane vesicles. The transport activity was evaluated as MRP4-mediated transport per MRP4 protein [nL/(min·fmol MRP4 protein)] based on measurement of MRP4 protein expression by means of liquid chromatography-tandem mass spectrometry. Cefotiam showed the greatest MRP4-mediated transport activity [8.90 nL/(min·fmol MRP4 protein)] among the β-lactam antibiotics examined in this study. Measurements of differential transport activity of MRP4 for various β-lactam antibiotics indicated that (i) cephalosporins were transported via MRP4 at a greater rate than were penams, β-lactamase inhibitors, penems, or monobactams; (ii) MRP4-mediated transport activity of anionic cephalosporins was greater than that of zwitterionic cephalosporins; and (iii) higher-molecular-weight anionic β-lactam antibiotics showed greater MRP4-mediated transport activity than lower-molecular-weight ones, whereas zwitterionic β-lactam antibiotics did not show molecular weight dependency of MRP4-mediated transport. These quantitative data should prove useful for understanding MRP-related adverse effects of β-lactam antibiotics and their derivatives.
Insights
Multidrug resistance-associated protein 4 (MRP4) transports beta-lactam antibiotics, influencing their brain distribution. This study quantifies transport activity, revealing cephalosporins are most affected, aiding understanding of adverse drug effects.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Metabolism
Background:
- Beta-lactam antibiotics can cause cerebral and peripheral adverse effects.
- Multidrug resistance-associated protein 4 (MRP4) is implicated in transporting beta-lactam antibiotics and limiting their brain entry via the blood-brain barrier.
Purpose of the Study:
- To elucidate the structure-activity relationship of MRP4-mediated transport for various beta-lactam antibiotics.
- To quantify the transport activity of MRP4 for different classes of beta-lactam antibiotics.
Main Methods:
- Utilized MRP4-expressing Sf9 membrane vesicles to assess transport activity.
- Quantified MRP4 protein expression using liquid chromatography-tandem mass spectrometry.
- Evaluated transport activity as MRP4-mediated transport per MRP4 protein (nL/min·fmol).
Main Results:
- Cefotiam exhibited the highest MRP4-mediated transport activity (8.90 nL/min·fmol).
- Cephalosporins showed greater MRP4 transport than penams, beta-lactamase inhibitors, penems, or monobactams.
- Anionic cephalosporins and higher-molecular-weight anionic beta-lactams were transported more efficiently by MRP4 than their zwitterionic or lower-molecular-weight counterparts.
Conclusions:
- Quantitative data on MRP4 transport of beta-lactam antibiotics provide insights into structure-activity relationships.
- Findings aid in understanding MRP4-related adverse effects of beta-lactam antibiotics and their derivatives.
- Differential transport kinetics highlight the influence of chemical properties on MRP4 interaction.
More Related Videos
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Mechanism of Antibiotic Resistance in MRSA
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

